Plain-English translation of NCT04457154 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study that tracks young adults (ages 18–21) who receive the Inspire Upper Airway Stimulation System, a small implanted device that helps treat moderate to severe obstructive sleep apnea. The device works by gently stimulating the upper airway muscles during sleep to keep the airway open and reduce breathing interruptions. Researchers will follow participants for 5 years after implantation to understand how safe and effective this treatment is in this younger age group.
Obstructive sleep apnea can be serious, but not all patients can tolerate or benefit from standard treatments like CPAP machines or surgery. This registry exists to gather real-world safety and effectiveness data on this implanted device in young adults, helping doctors understand whether it's a good option for patients in this age group who haven't had success with other treatments.
You likely qualify if…
You likely don't qualify if…
If you enroll, you'll have surgery to implant the Inspire device. After implantation, you'll visit the clinic at 1 month (activation), 6 months, and then at years 1, 2, 3, 4, and 5 post-implant. At each visit, you'll complete sleep studies (some at home, some in a lab), answer questions about how you're doing, and discuss any side effects. Throughout the 5-year period, you'll use the patient remote control to activate the device nightly.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States